Literature DB >> 16460811

Interleukin-18 mRNA expression in the rat pituitary gland.

N Wang1, S Sugama, B Conti, A Teramoto, T Shibasaki.   

Abstract

The present study investigated the expression of IL-18 mRNA under several stimuli, and molecular structures of IL-18 mRNA of the rat pituitary. Real-time PCR demonstrated that IL-18 mRNA, highly expressed in anterior pituitary, significantly increased following stress and adrenalectomy. In situ hybridization combined with immunohistochemistry demonstrated that corticotrope cells expressed IL-18 mRNA. RACE and sequence analysis demonstrated that pituitary IL-18 mRNA possesses five new exons at the upstream of exon 1 and between exon 1 and exon 2, indicating the preferential usage of promoter 1. The present study suggests that IL-18 in the corticotrope cells may play some roles in stress responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460811     DOI: 10.1016/j.jneuroim.2005.12.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice.

Authors:  Eric P Zorrilla; Bruno Conti
Journal:  Brain Behav Immun       Date:  2013-12-06       Impact factor: 7.217

2.  Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency.

Authors:  Eric P Zorrilla; Manuel Sanchez-Alavez; Shuei Sugama; Molly Brennan; Rosette Fernandez; Tamas Bartfai; Bruno Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 3.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

4.  Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain.

Authors:  Silvia Alboni; Davide Cervia; Brendon Ross; Claudia Montanari; Alejandro Sanchez Gonzalez; Manuel Sanchez-Alavez; Maria Cecilia Garibaldi Marcondes; David De Vries; Shuei Sugama; Nicoletta Brunello; Joan Blom; Fabio Tascedda; Bruno Conti
Journal:  J Neuroimmunol       Date:  2009-07-28       Impact factor: 3.478

5.  A comprehensive pathway map of IL-18-mediated signalling.

Authors:  D A B Rex; Nupur Agarwal; T S Keshava Prasad; Richard K Kandasamy; Yashwanth Subbannayya; Sneha M Pinto
Journal:  J Cell Commun Signal       Date:  2019-12-20       Impact factor: 5.782

6.  Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.

Authors:  Alan Prossin; Alisa Koch; Phillip Campbell; Geoffroy Laumet; Christian S Stohler; Robert Dantzer; Jon-Kar Zubieta
Journal:  Mol Psychiatry       Date:  2021-10-29       Impact factor: 13.437

7.  Effects of IFN-γ on IL-18 Expression in Pregnant Rats and Pregnancy Outcomes.

Authors:  Li-Fang Si; Shou-Yan Zhang; Chun-Sheng Gao; Shu-Lin Chen; Jin Zhao; Xiang-Chao Cheng
Journal:  Asian-Australas J Anim Sci       Date:  2013-10       Impact factor: 2.509

8.  Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction.

Authors:  A R Prossin; A E Koch; P L Campbell; T Barichello; S S Zalcman; J-K Zubieta
Journal:  Mol Psychiatry       Date:  2015-08-18       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.